Insider · CIK 0001713893

Bodem Barbara W.

Reports to the SEC for 8 companies · SAN RAFAEL, CA

sec.gov

Transactions

Companies

Filings

CIK

0001713893

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-02	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+7,490 sh	—	—	21,045
2026-05-20	OPCHOption Care Health, Inc.A Award	Director	AAward	+8,997 sh	—	—	21,087
2026-05-19	ENOVEnovis CORPA Award	Director	AAward	+9,346 sh	—	—	24,201
2025-05-21	ENOVEnovis CORPA Award	Director	AAward	+6,598 sh	—	—	14,855
2025-05-20	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+6,650 sh	—	—	13,555
2025-05-14	OPCHOption Care Health, Inc.A Award	Director	AAward	+5,034 sh	—	—	12,090
2024-05-21	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,720 sh	—	—	6,900
2024-05-20	ENOVEnovis CORPA Award	Director	AAward	+4,338 sh	—	—	8,257
2024-05-15	OPCHOption Care Health, Inc.A Award	Director	AAward	+5,325 sh	—	—	7,056
2024-04-01	OPCHOption Care Health, Inc.A Award	Director	AAward	+1,731 sh	—	—	1,731
2023-12-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,180 sh	—	—	2,180
2023-09-28	Syneos Health, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3,522 sh	$43.00	−$151K	4,863
2023-09-28	Syneos Health, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−4,863 sh	—	—	0
2023-05-25	Syneos Health, Inc.A Award	Director	AAward	+4,863 sh	—	—	8,385
2023-05-16	ENOVEnovis CORPA Award	Director	AAward	+1,875 sh	—	—	3,919
2023-05-16	ENOVEnovis CORP · Director stock option (right to buy)A Award	Director	AAward	+4,167 sh	—	—	4,167
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2022-06-07	ENOVEnovis CORPA Award	Director	AAward	+1,648 sh	—	—	2,044
2022-06-07	ENOVEnovis CORP · Director Stock Option (right to buy)A Award	Director	AAward	+3,464 sh	—	—	3,464
2022-06-07	ENOVEnovis CORPA Award	Director	AAward	+396 sh	—	—	396
2022-05-25	Syneos Health, Inc.A Award	Director	AAward	+2,839 sh	—	—	3,522
2022-01-18	Syneos Health, Inc.A Award	Director	AAward	+654 sh	—	—	683
2021-12-13	Hill-Rom Holdings, Inc.Restricted Stock Units (11/06/2019)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−1,253 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−14K sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−10.3K sh	$57.24	−$588K	0
2021-12-13	Hill-Rom Holdings, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−15.5K sh	$52.89	−$819K	0
2021-12-13	Hill-Rom Holdings, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−17.9K sh	$61.86	−$1.11M	0
2021-12-13	Hill-Rom Holdings, Inc.Performance-Based Restricted Stock Units (11/06/2019)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−7,452 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Performance-Based Restricted Stock Units (11/11/2020)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−9,091 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Restricted Stock Units (11/11/2020)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−3,026 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Restricted Stock Units (11/10/2021)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−14K sh	—	—	0
2021-12-06	Hill-Rom Holdings, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+992 sh	—	—	14,321
2021-12-06	Hill-Rom Holdings, Inc.Restricted Stock Units (12/03/2018)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−2,640 sh	—	—	0
2021-12-06	Hill-Rom Holdings, Inc.Restricted Stock Units (12/03/2018) LTIM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−992 sh	—	—	0
2021-12-06	Hill-Rom Holdings, Inc.G Gift	SVP, Chief Financial Officer	GGift	−2,000 sh	—	—	13,321
2021-12-06	Hill-Rom Holdings, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−1,192 sh	$155.73	−$186K	15,321
2021-12-06	Hill-Rom Holdings, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+2,640 sh	—	—	16,513
2021-12-06	Hill-Rom Holdings, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−448 sh	$155.73	−$69.8K	13,873
2021-11-12	Hill-Rom Holdings, Inc.Restricted Stock Units (11/11/2020)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−1,557 sh	—	—	2,989
2021-11-12	Hill-Rom Holdings, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+1,557 sh	—	—	14,028
2021-11-12	Hill-Rom Holdings, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−699 sh	$155.11	−$108K	13,329
2021-11-10	Hill-Rom Holdings, Inc.Restricted Stock Units (11/10/2021)A Award	SVP, Chief Financial Officer	AAward	+14K sh	—	—	13,951
2021-11-08	Hill-Rom Holdings, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−561 sh	$155.09	−$87K	12,471
2021-11-08	Hill-Rom Holdings, Inc.Restricted Stock Units (11/06/2019)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−1,249 sh	—	—	1,232.427
2021-11-08	Hill-Rom Holdings, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+1,249 sh	—	—	13,032
2021-11-01	Hill-Rom Holdings, Inc.A Award	SVP, Chief Financial Officer	AAward	+9,017 sh	—	—	14,885
2021-11-01	Hill-Rom Holdings, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−3,102 sh	$155.17	−$481K	11,783
2021-03-31	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	14,995
2020-12-04	Hill-Rom Holdings, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+980 sh	$95.79	+$93.9K	4,379
2020-12-04	Hill-Rom Holdings, Inc.Restricted Stock Units (12/03/2018)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−2,616 sh	—	—	2,618.643

Recent filings

Accepted (ET)
Jun 44
Bodem Barbara W.0001628280-26-040907
SEC(opens sec.gov)
May 224
Bodem Barbara W.0001437749-26-018298
SEC(opens sec.gov)
May 214
Bodem Barbara W.0001193125-26-235176
SEC(opens sec.gov)
May 234
Bodem Barbara W.0000950170-25-077285
SEC(opens sec.gov)
May 224
Bodem Barbara W.0001048477-25-000064
SEC(opens sec.gov)
May 194
Bodem Barbara W.0001437749-25-017669
SEC(opens sec.gov)
May 234
Bodem Barbara W.0001048477-24-000094
SEC(opens sec.gov)
May 224
Bodem Barbara W.0000950170-24-063717
SEC(opens sec.gov)
May 174
Bodem Barbara W.0001437749-24-017506
SEC(opens sec.gov)
Apr 34
Bodem Barbara W.0001437749-24-010937
SEC(opens sec.gov)
Dec 284
Bodem Barbara W.0001048477-23-000076
SEC(opens sec.gov)
Sep 284
Bodem Barbara W.0001209191-23-050771
SEC(opens sec.gov)
May 304
Bodem Barbara W.0001209191-23-032938
SEC(opens sec.gov)
May 184
Bodem Barbara W.0001209191-23-030806
SEC(opens sec.gov)
Aug 174
Bodem Barbara W.0001209191-22-046283
SEC(opens sec.gov)
Jun 94
Bodem Barbara W.0001209191-22-035602
SEC(opens sec.gov)

Companies

Address

C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO STREET

SAN RAFAEL, CA, 94901